Hydrocortisone in Severe Community-Acquired Pneumonia
In this randomized trial, hydrocortisone treatment decreased mortality among patients with severe community-acquired pneumonia in the ICU.
Saved in:
Published in | The New England journal of medicine Vol. 388; no. 21; pp. 1931 - 1941 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Massachusetts Medical Society
25.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In this randomized trial, hydrocortisone treatment decreased mortality among patients with severe community-acquired pneumonia in the ICU. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJMoa2215145 |